Sale disclosed
Donald W. DeGolyer
Director
Common Stock
- Reported value
- $126.2K
- Reported price
- $7.09 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Emergent BioSolutions Inc.
Last 30 daysNo qualifying insider buying. Sales: $145.79K by 2 insiders.
Showing the first 6 of 20 trades on this page.
Director
Common Stock
SVP, Products Business
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Common Stock
SVP, Products Business
Common Stock
SVP, Products Business
Common Stock
EVP, Chief Financial Officer
Common Stock
EVP, Quality & Ethics, and CPL
Common Stock
SVP, Bioservices
Common Stock
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
Director
Common Stock
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
Director
Common Stock
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
Director
Stock Options (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockSale10b5-1 | 17,800$7.09 / share | $126.2K | Oct 7Filed Oct 7 · 0d later | SEC filing |
| SVP, Products Business | Common StockSale10b5-1 | 3,000$6.53 / share | $19.59K | Oct 1Filed Oct 5 · 4d later | SEC filing |
| SVP, Products Business | Common StockSale10b5-1 | 3,000$8.40 / share | $25.2K | Jul 1Filed Jul 2 · 1d later | SEC filing |
| SVP, Products Business | Common StockExercise-price or tax withholding | 694$8.00 / share | $5.55K | Jun 8Filed Jun 10 · 2d later | SEC filing |
| EVP, Chief Financial Officer | Common StockExercise-price or tax withholding | 3,964$8.00 / share | $31.71K | Jun 8Filed Jun 10 · 2d later | SEC filing |
| EVP, Quality & Ethics, and CPL | Common StockExercise-price or tax withholding | 2,018$8.00 / share | $16.14K | Jun 8Filed Jun 10 · 2d later | SEC filing |
| SVP, Bioservices | Common StockExercise-price or tax withholding | 1,741$8.00 / share | $13.93K | Jun 8Filed Jun 10 · 2d later | SEC filing |
| Director | Common StockGrant or award10b5-1 | 25,344Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Common StockSale10b5-12 trades | 13,761avg $8.40 / share | $115.61K | May 1Filed May 4 · 3d later | 2 filings
|
| Director | Stock Option (Right to Buy)Grant or award10b5-1 | Derivative units11,296Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Common StockGrant or award10b5-1 | 25,344Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Common StockSale10b5-12 trades | 15,481avg $8.40 / share | $129.99K | May 1Filed May 4 · 3d later | 2 filings
|
| Director | Stock Option (Right to Buy)Grant or award10b5-1 | Derivative units11,296Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Common StockGrant or award10b5-1 | 25,344Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Common StockSale10b5-1 | 15,481$8.28 / share | $128.18K | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Stock Options (Right to Buy)Grant or award10b5-1 | Derivative units11,296Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Common StockGrant or award | 25,344Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units11,296Award · no purchase price | Non-cash award | Apr 30Filed May 4 · 4d later | SEC filing |
Showing the latest 20 of 40 trades. Show all 40 trades
This reflects the filings imported so far, not a complete trading history.